Novartis announces phase III NATALEE trial of Kisqali reduces risk of recurrence in younger patients with early breast cancer: Basel Tuesday, June 3, 2025, 18:00 Hrs [IST] Novarti ...

PCOS, a prevalent hormonal disorder, poses challenges to conception, especially among young women. However, with early ...

High testosterone in women can stem from conditions like PCOS and insulin resistance. Symptoms may include acne, excess hair ...

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

Novo Nordisk has launched a direct-to-consumer (DTC) option for uninsured or under-insured people wanting to access its GLP-1 agonist weight-loss drug Wegovy, cutting the drug's price in half to $ ...

But first, we explain what causes nasal congestion and how decongestant drugs work. Although people often think nasal congestion is caused by excess mucus, it’s actually a result of swollen ...